Drug-Coated Balloons-Asia Pacific Market Status and Trend Report 2013-2023
Report Summary
Drug-Coated Balloons-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug-Coated Balloons industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Asia Pacific and Regional Market Size of Drug-Coated Balloons 2013-2017, and development forecast 2018-2023
Main market players of Drug-Coated Balloons in Asia Pacific, with company and product introduction, position in the Drug-Coated Balloons market
Market status and development trend of Drug-Coated Balloons by types and applications
Cost and profit status of Drug-Coated Balloons, and marketing status
Market growth drivers and challenges
The report segments the Asia Pacific Drug-Coated Balloons market as:
Asia Pacific Drug-Coated Balloons Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
China
Japan
Korea
India
Southeast Asia
Australia
Asia Pacific Drug-Coated Balloons Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
Asia Pacific Drug-Coated Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Ambulatory Surgical Centers
Other
Asia Pacific Drug-Coated Balloons Market: Players Segment Analysis (Company and Product introduction, Drug-Coated Balloons Sales Volume, Revenue, Price and Gross Margin):
Natec Medical
Cook Medical
Medtronic
C.R. Bard
Boston Scientific
Spectranetics Corporation
Endocor GmbH
Biotronik
Cordis Corporation
Abbott Laboratories
Smiths Medical
Opto Circuits
Asahi Intecc
Angioslide
Tokai Medical
Atrium Medical
Lepu Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Drug-Coated Balloons-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Drug-Coated Balloons industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Asia Pacific and Regional Market Size of Drug-Coated Balloons 2013-2017, and development forecast 2018-2023
Main market players of Drug-Coated Balloons in Asia Pacific, with company and product introduction, position in the Drug-Coated Balloons market
Market status and development trend of Drug-Coated Balloons by types and applications
Cost and profit status of Drug-Coated Balloons, and marketing status
Market growth drivers and challenges
The report segments the Asia Pacific Drug-Coated Balloons market as:
Asia Pacific Drug-Coated Balloons Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
China
Japan
Korea
India
Southeast Asia
Australia
Asia Pacific Drug-Coated Balloons Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Semi-Compliant Balloons
Non-Compliant Balloons
Asia Pacific Drug-Coated Balloons Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospitals
Clinics
Ambulatory Surgical Centers
Other
Asia Pacific Drug-Coated Balloons Market: Players Segment Analysis (Company and Product introduction, Drug-Coated Balloons Sales Volume, Revenue, Price and Gross Margin):
Natec Medical
Cook Medical
Medtronic
C.R. Bard
Boston Scientific
Spectranetics Corporation
Endocor GmbH
Biotronik
Cordis Corporation
Abbott Laboratories
Smiths Medical
Opto Circuits
Asahi Intecc
Angioslide
Tokai Medical
Atrium Medical
Lepu Medical
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF DRUG-COATED BALLOONS
1.1 Definition of Drug-Coated Balloons in This Report
1.2 Commercial Types of Drug-Coated Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Coated Balloons
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 Development History of Drug-Coated Balloons
1.5 Market Status and Trend of Drug-Coated Balloons 2013-2023
1.5.1 Asia Pacific Drug-Coated Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Coated Balloons Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug-Coated Balloons in Asia Pacific 2013-2017
2.2 Consumption Market of Drug-Coated Balloons in Asia Pacific by Regions
2.2.1 Consumption Volume of Drug-Coated Balloons in Asia Pacific by Regions
2.2.2 Revenue of Drug-Coated Balloons in Asia Pacific by Regions
2.3 Market Analysis of Drug-Coated Balloons in Asia Pacific by Regions
2.3.1 Market Analysis of Drug-Coated Balloons in China 2013-2017
2.3.2 Market Analysis of Drug-Coated Balloons in Japan 2013-2017
2.3.3 Market Analysis of Drug-Coated Balloons in Korea 2013-2017
2.3.4 Market Analysis of Drug-Coated Balloons in India 2013-2017
2.3.5 Market Analysis of Drug-Coated Balloons in Southeast Asia 2013-2017
2.3.6 Market Analysis of Drug-Coated Balloons in Australia 2013-2017
2.4 Market Development Forecast of Drug-Coated Balloons in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Drug-Coated Balloons in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Drug-Coated Balloons by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Drug-Coated Balloons in Asia Pacific by Types
3.1.2 Revenue of Drug-Coated Balloons in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Drug-Coated Balloons in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug-Coated Balloons in Asia Pacific by Downstream Industry
4.2 Demand Volume of Drug-Coated Balloons by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug-Coated Balloons by Downstream Industry in China
4.2.2 Demand Volume of Drug-Coated Balloons by Downstream Industry in Japan
4.2.3 Demand Volume of Drug-Coated Balloons by Downstream Industry in Korea
4.2.4 Demand Volume of Drug-Coated Balloons by Downstream Industry in India
4.2.5 Demand Volume of Drug-Coated Balloons by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Drug-Coated Balloons by Downstream Industry in Australia
4.3 Market Forecast of Drug-Coated Balloons in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG-COATED BALLOONS
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Drug-Coated Balloons Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG-COATED BALLOONS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Drug-Coated Balloons in Asia Pacific by Major Players
6.2 Revenue of Drug-Coated Balloons in Asia Pacific by Major Players
6.3 Basic Information of Drug-Coated Balloons by Major Players
6.3.1 Headquarters Location and Established Time of Drug-Coated Balloons Major Players
6.3.2 Employees and Revenue Level of Drug-Coated Balloons Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG-COATED BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Natec Medical
7.1.1 Company profile
7.1.2 Representative Drug-Coated Balloons Product
7.1.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Natec Medical
7.2 Cook Medical
7.2.1 Company profile
7.2.2 Representative Drug-Coated Balloons Product
7.2.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
7.3 Medtronic
7.3.1 Company profile
7.3.2 Representative Drug-Coated Balloons Product
7.3.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Medtronic
7.4 C.R. Bard
7.4.1 Company profile
7.4.2 Representative Drug-Coated Balloons Product
7.4.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
7.5 Boston Scientific
7.5.1 Company profile
7.5.2 Representative Drug-Coated Balloons Product
7.5.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
7.6 Spectranetics Corporation
7.6.1 Company profile
7.6.2 Representative Drug-Coated Balloons Product
7.6.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Spectranetics Corporation
7.7 Endocor GmbH
7.7.1 Company profile
7.7.2 Representative Drug-Coated Balloons Product
7.7.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Endocor GmbH
7.8 Biotronik
7.8.1 Company profile
7.8.2 Representative Drug-Coated Balloons Product
7.8.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Biotronik
7.9 Cordis Corporation
7.9.1 Company profile
7.9.2 Representative Drug-Coated Balloons Product
7.9.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cordis Corporation
7.10 Abbott Laboratories
7.10.1 Company profile
7.10.2 Representative Drug-Coated Balloons Product
7.10.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.11 Smiths Medical
7.11.1 Company profile
7.11.2 Representative Drug-Coated Balloons Product
7.11.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Smiths Medical
7.12 Opto Circuits
7.12.1 Company profile
7.12.2 Representative Drug-Coated Balloons Product
7.12.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Opto Circuits
7.13 Asahi Intecc
7.13.1 Company profile
7.13.2 Representative Drug-Coated Balloons Product
7.13.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Asahi Intecc
7.14 Angioslide
7.14.1 Company profile
7.14.2 Representative Drug-Coated Balloons Product
7.14.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Angioslide
7.15 Tokai Medical
7.15.1 Company profile
7.15.2 Representative Drug-Coated Balloons Product
7.15.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Tokai Medical
7.16 Atrium Medical
7.17 Lepu Medical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-COATED BALLOONS
8.1 Industry Chain of Drug-Coated Balloons
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG-COATED BALLOONS
9.1 Cost Structure Analysis of Drug-Coated Balloons
9.2 Raw Materials Cost Analysis of Drug-Coated Balloons
9.3 Labor Cost Analysis of Drug-Coated Balloons
9.4 Manufacturing Expenses Analysis of Drug-Coated Balloons
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG-COATED BALLOONS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Drug-Coated Balloons in This Report
1.2 Commercial Types of Drug-Coated Balloons
1.2.1 Semi-Compliant Balloons
1.2.2 Non-Compliant Balloons
1.3 Downstream Application of Drug-Coated Balloons
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgical Centers
1.3.4 Other
1.4 Development History of Drug-Coated Balloons
1.5 Market Status and Trend of Drug-Coated Balloons 2013-2023
1.5.1 Asia Pacific Drug-Coated Balloons Market Status and Trend 2013-2023
1.5.2 Regional Drug-Coated Balloons Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Drug-Coated Balloons in Asia Pacific 2013-2017
2.2 Consumption Market of Drug-Coated Balloons in Asia Pacific by Regions
2.2.1 Consumption Volume of Drug-Coated Balloons in Asia Pacific by Regions
2.2.2 Revenue of Drug-Coated Balloons in Asia Pacific by Regions
2.3 Market Analysis of Drug-Coated Balloons in Asia Pacific by Regions
2.3.1 Market Analysis of Drug-Coated Balloons in China 2013-2017
2.3.2 Market Analysis of Drug-Coated Balloons in Japan 2013-2017
2.3.3 Market Analysis of Drug-Coated Balloons in Korea 2013-2017
2.3.4 Market Analysis of Drug-Coated Balloons in India 2013-2017
2.3.5 Market Analysis of Drug-Coated Balloons in Southeast Asia 2013-2017
2.3.6 Market Analysis of Drug-Coated Balloons in Australia 2013-2017
2.4 Market Development Forecast of Drug-Coated Balloons in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Drug-Coated Balloons in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Drug-Coated Balloons by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Drug-Coated Balloons in Asia Pacific by Types
3.1.2 Revenue of Drug-Coated Balloons in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Drug-Coated Balloons in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Drug-Coated Balloons in Asia Pacific by Downstream Industry
4.2 Demand Volume of Drug-Coated Balloons by Downstream Industry in Major Countries
4.2.1 Demand Volume of Drug-Coated Balloons by Downstream Industry in China
4.2.2 Demand Volume of Drug-Coated Balloons by Downstream Industry in Japan
4.2.3 Demand Volume of Drug-Coated Balloons by Downstream Industry in Korea
4.2.4 Demand Volume of Drug-Coated Balloons by Downstream Industry in India
4.2.5 Demand Volume of Drug-Coated Balloons by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Drug-Coated Balloons by Downstream Industry in Australia
4.3 Market Forecast of Drug-Coated Balloons in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF DRUG-COATED BALLOONS
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Drug-Coated Balloons Downstream Industry Situation and Trend Overview
CHAPTER 6 DRUG-COATED BALLOONS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Drug-Coated Balloons in Asia Pacific by Major Players
6.2 Revenue of Drug-Coated Balloons in Asia Pacific by Major Players
6.3 Basic Information of Drug-Coated Balloons by Major Players
6.3.1 Headquarters Location and Established Time of Drug-Coated Balloons Major Players
6.3.2 Employees and Revenue Level of Drug-Coated Balloons Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 DRUG-COATED BALLOONS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Natec Medical
7.1.1 Company profile
7.1.2 Representative Drug-Coated Balloons Product
7.1.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Natec Medical
7.2 Cook Medical
7.2.1 Company profile
7.2.2 Representative Drug-Coated Balloons Product
7.2.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cook Medical
7.3 Medtronic
7.3.1 Company profile
7.3.2 Representative Drug-Coated Balloons Product
7.3.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Medtronic
7.4 C.R. Bard
7.4.1 Company profile
7.4.2 Representative Drug-Coated Balloons Product
7.4.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of C.R. Bard
7.5 Boston Scientific
7.5.1 Company profile
7.5.2 Representative Drug-Coated Balloons Product
7.5.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Boston Scientific
7.6 Spectranetics Corporation
7.6.1 Company profile
7.6.2 Representative Drug-Coated Balloons Product
7.6.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Spectranetics Corporation
7.7 Endocor GmbH
7.7.1 Company profile
7.7.2 Representative Drug-Coated Balloons Product
7.7.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Endocor GmbH
7.8 Biotronik
7.8.1 Company profile
7.8.2 Representative Drug-Coated Balloons Product
7.8.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Biotronik
7.9 Cordis Corporation
7.9.1 Company profile
7.9.2 Representative Drug-Coated Balloons Product
7.9.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Cordis Corporation
7.10 Abbott Laboratories
7.10.1 Company profile
7.10.2 Representative Drug-Coated Balloons Product
7.10.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.11 Smiths Medical
7.11.1 Company profile
7.11.2 Representative Drug-Coated Balloons Product
7.11.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Smiths Medical
7.12 Opto Circuits
7.12.1 Company profile
7.12.2 Representative Drug-Coated Balloons Product
7.12.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Opto Circuits
7.13 Asahi Intecc
7.13.1 Company profile
7.13.2 Representative Drug-Coated Balloons Product
7.13.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Asahi Intecc
7.14 Angioslide
7.14.1 Company profile
7.14.2 Representative Drug-Coated Balloons Product
7.14.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Angioslide
7.15 Tokai Medical
7.15.1 Company profile
7.15.2 Representative Drug-Coated Balloons Product
7.15.3 Drug-Coated Balloons Sales, Revenue, Price and Gross Margin of Tokai Medical
7.16 Atrium Medical
7.17 Lepu Medical
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF DRUG-COATED BALLOONS
8.1 Industry Chain of Drug-Coated Balloons
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF DRUG-COATED BALLOONS
9.1 Cost Structure Analysis of Drug-Coated Balloons
9.2 Raw Materials Cost Analysis of Drug-Coated Balloons
9.3 Labor Cost Analysis of Drug-Coated Balloons
9.4 Manufacturing Expenses Analysis of Drug-Coated Balloons
CHAPTER 10 MARKETING STATUS ANALYSIS OF DRUG-COATED BALLOONS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
